CN117205213A - 白鲜碱在制备鱼类病毒性神经坏死病药物中的用途 - Google Patents
白鲜碱在制备鱼类病毒性神经坏死病药物中的用途 Download PDFInfo
- Publication number
- CN117205213A CN117205213A CN202311465685.2A CN202311465685A CN117205213A CN 117205213 A CN117205213 A CN 117205213A CN 202311465685 A CN202311465685 A CN 202311465685A CN 117205213 A CN117205213 A CN 117205213A
- Authority
- CN
- China
- Prior art keywords
- dictamnine
- nervous necrosis
- groupers
- necrosis virus
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WIONIXOBNMDJFJ-UHFFFAOYSA-N Dictamnine Chemical compound C1=CC=C2C(OC)=C(C=CO3)C3=NC2=C1 WIONIXOBNMDJFJ-UHFFFAOYSA-N 0.000 title claims abstract description 158
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 25
- 230000017074 necrotic cell death Effects 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 230000003612 virological effect Effects 0.000 title claims abstract description 12
- 206010028851 Necrosis Diseases 0.000 title abstract description 14
- 229940079593 drug Drugs 0.000 title abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 108090000565 Capsid Proteins Proteins 0.000 claims abstract description 20
- 102100023321 Ceruloplasmin Human genes 0.000 claims abstract description 20
- 230000000694 effects Effects 0.000 claims abstract description 15
- 241001492212 Striped Jack nervous necrosis virus Species 0.000 claims abstract description 14
- 208000015181 infectious disease Diseases 0.000 claims description 11
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 210000005036 nerve Anatomy 0.000 claims description 4
- 230000010076 replication Effects 0.000 claims description 4
- 231100000915 pathological change Toxicity 0.000 claims description 3
- 230000036285 pathological change Effects 0.000 claims description 3
- 241001417495 Serranidae Species 0.000 abstract description 31
- 230000004083 survival effect Effects 0.000 abstract description 13
- 238000011160 research Methods 0.000 abstract description 6
- 231100000645 Reed–Muench method Toxicity 0.000 abstract description 3
- 238000009360 aquaculture Methods 0.000 abstract description 3
- 244000144974 aquaculture Species 0.000 abstract description 3
- 208000031295 Animal disease Diseases 0.000 abstract description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 241000700605 Viruses Species 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 238000011529 RT qPCR Methods 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 230000000120 cytopathologic effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 6
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 5
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 5
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 4
- 206010070863 Toxicity to various agents Diseases 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 238000007865 diluting Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000158512 Redspotted grouper nervous necrosis virus Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- FQZJYWMRQDKBQN-UHFFFAOYSA-N tricaine methanesulfonate Chemical compound CS([O-])(=O)=O.CCOC(=O)C1=CC=CC([NH3+])=C1 FQZJYWMRQDKBQN-UHFFFAOYSA-N 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 240000000774 Cunila origanoides Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000357444 Epinephelus coioides Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101150023114 RNA1 gene Proteins 0.000 description 1
- 101150084101 RNA2 gene Proteins 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 101100353432 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PRP2 gene Proteins 0.000 description 1
- 241000630524 Taractes rubescens Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311465685.2A CN117205213B (zh) | 2023-11-07 | 2023-11-07 | 白鲜碱在制备鱼类病毒性神经坏死病药物中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311465685.2A CN117205213B (zh) | 2023-11-07 | 2023-11-07 | 白鲜碱在制备鱼类病毒性神经坏死病药物中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117205213A true CN117205213A (zh) | 2023-12-12 |
CN117205213B CN117205213B (zh) | 2024-03-29 |
Family
ID=89044769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311465685.2A Active CN117205213B (zh) | 2023-11-07 | 2023-11-07 | 白鲜碱在制备鱼类病毒性神经坏死病药物中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117205213B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189403A (zh) * | 2014-07-30 | 2014-12-10 | 严中明 | 病毒性坏死病的防治粉剂 |
CN104189480A (zh) * | 2014-07-30 | 2014-12-10 | 严中明 | 抑制海鱼病毒性神经坏死病病毒的中药粉 |
KR20170006690A (ko) * | 2015-07-09 | 2017-01-18 | 대한민국(관리부서:국립수산과학원) | 바이러스성 신경괴사증 내병성 능성어 생산방법 |
CN115992143A (zh) * | 2022-07-20 | 2023-04-21 | 广西科学院 | 一种抗神经坏死病毒的高通量药物筛选方法 |
-
2023
- 2023-11-07 CN CN202311465685.2A patent/CN117205213B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189403A (zh) * | 2014-07-30 | 2014-12-10 | 严中明 | 病毒性坏死病的防治粉剂 |
CN104189480A (zh) * | 2014-07-30 | 2014-12-10 | 严中明 | 抑制海鱼病毒性神经坏死病病毒的中药粉 |
KR20170006690A (ko) * | 2015-07-09 | 2017-01-18 | 대한민국(관리부서:국립수산과학원) | 바이러스성 신경괴사증 내병성 능성어 생산방법 |
CN115992143A (zh) * | 2022-07-20 | 2023-04-21 | 广西科学院 | 一种抗神经坏死病毒的高通量药物筛选方法 |
Non-Patent Citations (1)
Title |
---|
魏盟智;李亚军;安鑫龙;邓晓东;: "石斑鱼病毒性神经坏死病防治的研究现状", 河北渔业, no. 05, pages 142 - 57 * |
Also Published As
Publication number | Publication date |
---|---|
CN117205213B (zh) | 2024-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101724218B1 (ko) | 식물 마이크로 리보핵산의 추출, 제조 및 그 응용 | |
CN111172119B (zh) | 具有宽裂解谱的新副溶血弧菌噬菌体、其特异性引物及其应用 | |
CN111135184A (zh) | GS-441524在制备新型冠状病毒SARS-CoV-2抑制剂中的应用 | |
CN104887694B (zh) | 一种靶向非编码rna的反义寡核苷酸及其在制备抗流感病毒药物中的应用 | |
CN111803494B (zh) | 褪黑素在制备抗肠道病毒药物中的应用 | |
CN117205213B (zh) | 白鲜碱在制备鱼类病毒性神经坏死病药物中的用途 | |
CN106880630B (zh) | Retro-2cycl及相关衍生物的用途 | |
WO2013189003A1 (zh) | J亚群禽白血病病毒的肽核酸及其应用 | |
CN113616665B (zh) | 一种抗鱼类弹状病毒的复方中草药制剂 | |
CN113509489B (zh) | 含有亚硒酸钠的组合物在制备用于治疗非洲猪瘟的药物中的新用途 | |
CN107468682B (zh) | 芒果苷在制备抗病毒药物中的应用 | |
CN106957826B (zh) | 一种病毒灭活剂及其应用 | |
CN104394892B (zh) | 植物作为功能microRNA和/或功能siRNA运载体、制备方法及其应用 | |
CN113876751B (zh) | 竹红菌乙素在制备防治非洲猪瘟的药物中的应用 | |
EP1731159A1 (en) | Method of preventing nodavirus infection and therapeutic method | |
CN116098893B (zh) | 化合物Thapsigargin在制备预防或治疗猪流行性腹泻药物中的应用 | |
CN116942669B (zh) | 阿米洛利在制备防治鳜弹状病毒感染的药物中的应用 | |
CN113332290B (zh) | Voxtalisib化合物在制备抗EV71病毒药物中的应用 | |
CN114848616B (zh) | 枯茗醛在制备白斑综合症病毒抑制剂方面的应用 | |
CN116115610B (zh) | 一种小分子抑制剂bci121在鱼类抗病毒中的应用 | |
CN115869324B (zh) | Efavirenz在制备抗肠道病毒药物中的应用 | |
CN112920194B (zh) | 一种色烯类含氟功能基团的香豆素类衍生物及其制备方法和应用 | |
CN110946866B (zh) | 达匹维林在制备抑制鱼类病毒性出血性败血症病毒对细胞感染的药物中的应用 | |
CN117298096B (zh) | 异土木香内酯在抗大口黑鲈虹彩病毒活性中的应用 | |
RU2366709C1 (ru) | ШТАММ ВИРУСА ГРИППА ПТИЦ A/Goose/Krasnoozerskoye/627/05 СУБТИП Н5N1 ДЛЯ ИЗУЧЕНИЯ АКТИВНОСТИ ЛЕЧЕБНЫХ И ПРОФИЛАКТИЧЕСКИХ ПРЕПАРАТОВ ПРОТИВ ВИРУСА ГРИППА |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240222 Address after: 518000 Virtual University Park B406, R4 building, No. 19, Gaoxin South 4th Road, Yuehai street, Nanshan District, Shenzhen, Guangdong Applicant after: Shenzhen Research Institute of Northwest University of agriculture and forestry science and technology Country or region after: China Applicant after: GUANGXI ACADEMY OF SCIENCES Address before: 518000 Virtual University Park B406, R4 building, No. 19, Gaoxin South 4th Road, Yuehai street, Nanshan District, Shenzhen, Guangdong Applicant before: Shenzhen Research Institute of Northwest University of agriculture and forestry science and technology Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |